| Two bacterial species collaborate to drive development of colon cancers |
|
|
|
|
| |
February 5, 2018 |
|
| |
|
| |
The latest bowel cancer news from News Medical |
|
|
|
 | | |  Two bacterial species collaborate to drive development of colon cancers Patients with an inherited form of colon cancer harbor two bacterial species that collaborate to encourage development of the disease, and the same species have been found in people who develop a sporadic form of colon cancer, a study led by a Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy research team finds. | |
|
|
| | | | |  Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry. | | | | |  New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer. | | | | |  One small molecule that helps regulate gene expression plays a big role in keeping us safe from the machinations of cancer, scientists report. | | | | |  Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP). | | | | |  In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them. | |
|
|
|
|
|
|
|
